This SAGE PE ratio history page last updated 10/31/2024
Period | Price | GAAP | TTM | PE |
Q3 2024 10/29/2024 | 8.48 | -1.53 | -5.58 | NA | Q2 2024 7/31/2024 | 10.95 | -1.70 | -7.42 | NA | Q1 2024 4/25/2024 | 13.58 | -1.80 | -8.40 | NA | Q4 2023 2/14/2024 | 25.75 | -0.55 | -9.06 | NA | Q3 2023 11/7/2023 | 19.63 | -3.37 | -10.98 | NA | Q2 2023 8/7/2023 | 16.75 | -2.68 | -9.92 | NA | Q1 2023 5/2/2023 | 45.55 | -2.46 | -9.37 | NA | Q4 2022 2/16/2023 | 45.06 | -2.47 | -8.98 | NA | Q3 2022 11/8/2022 | 33.91 | -2.31 | -8.63 | NA | Q2 2022 8/2/2022 | 35.25 | -2.13 | -8.53 | NA | Q1 2022 5/3/2022 | 32.79 | -2.07 | -8.23 | NA | Q4 2021 2/24/2022 | 34.71 | -2.12 | -7.80 | NA | Q3 2021 11/2/2021 | 43.57 | -2.21 | 12.51 | 3.5 | Q2 2021 8/3/2021 | 41.76 | -1.83 | 12.69 | 3.3 | Q1 2021 5/4/2021 | 71.14 | -1.64 | 12.44 | 5.7 | Q4 2020 2/24/2021 | 85.04 | 18.19 | 11.64 | 7.3 | Q3 2020 11/5/2020 | 78.11 | -2.03 | -9.80 | NA | Q2 2020 8/10/2020 | 53.31 | -2.08 | -11.25 | NA | Q1 2020 5/7/2020 | 40.76 | -2.44 | -12.45 | NA | Q4 2019 2/27/2020 | 52.01 | -3.25 | -13.38 | NA | Q3 2019 11/12/2019 | 141.55 | -3.48 | -13.51 | NA | Q2 2019 8/6/2019 | 162.34 | -3.28 | -12.66 | NA | Q1 2019 5/2/2019 | 165.52 | -3.37 | -9.74 | NA | Q4 2018 2/19/2019 | 152.95 | -3.38 | -8.05 | NA | Q3 2018 11/6/2018 | 128.26 | -2.63 | -6.42 | NA | Q2 2018 8/7/2018 | 151.20 | -0.36 | -5.76 | NA | Q1 2018 5/3/2018 | 148.13 | -1.68 | -7.28 | NA | Q4 2017 2/22/2018 | 155.40 | -1.75 | -7.12 | NA | Q3 2017 11/2/2017 | 62.56 | -1.97 | -6.87 | NA | Q2 2017 8/3/2017 | 78.40 | -1.88 | -6.05 | NA | Q1 2017 5/9/2017 | 66.03 | -1.52 | -5.25 | NA | Q4 2016 2/23/2017 | 62.33 | -1.50 | -4.70 | NA | Q3 2016 11/3/2016 | 38.71 | -1.15 | -4.19 | NA | Q2 2016 8/9/2016 | 36.86 | -1.08 | -3.88 | NA | Q1 2016 5/5/2016 | 34.79 | -0.97 | -3.70 | NA | Q4 2015 2/24/2016 | 30.75 | -0.99 | -3.39 | NA | Q3 2015 11/5/2015 | 53.03 | -0.84 | -2.97 | NA | Q2 2015 8/12/2015 | 62.47 | -0.90 | -2.63 | NA | Q1 2015 5/14/2015 | 58.29 | -0.66 | -6.30 | NA | Q4 2014 2/27/2015 | 43.45 | -0.57 | NA | NA | Q3 2014 11/11/2014 | 33.98 | -0.50 | NA | NA | Q2 2014 8/14/2014 | 28.81 | -4.57 | NA | NA |
|
Period | Price | GAAP | Annualized | PE |
Q3 2024 10/29/2024 | 8.48 | -1.53 | -6.12 | NA | Q2 2024 7/31/2024 | 10.95 | -1.70 | -6.80 | NA | Q1 2024 4/25/2024 | 13.58 | -1.80 | -7.20 | NA | Q4 2023 2/14/2024 | 25.75 | -0.55 | -2.20 | NA | Q3 2023 11/7/2023 | 19.63 | -3.37 | -13.48 | NA | Q2 2023 8/7/2023 | 16.75 | -2.68 | -10.72 | NA | Q1 2023 5/2/2023 | 45.55 | -2.46 | -9.84 | NA | Q4 2022 2/16/2023 | 45.06 | -2.47 | -9.88 | NA | Q3 2022 11/8/2022 | 33.91 | -2.31 | -9.24 | NA | Q2 2022 8/2/2022 | 35.25 | -2.13 | -8.52 | NA | Q1 2022 5/3/2022 | 32.79 | -2.07 | -8.28 | NA | Q4 2021 2/24/2022 | 34.71 | -2.12 | -8.48 | NA | Q3 2021 11/2/2021 | 43.57 | -2.21 | -8.84 | NA | Q2 2021 8/3/2021 | 41.76 | -1.83 | -7.32 | NA | Q1 2021 5/4/2021 | 71.14 | -1.64 | -6.56 | NA | Q4 2020 2/24/2021 | 85.04 | 18.19 | 72.76 | 1.2 | Q3 2020 11/5/2020 | 78.11 | -2.03 | -8.12 | NA | Q2 2020 8/10/2020 | 53.31 | -2.08 | -8.32 | NA | Q1 2020 5/7/2020 | 40.76 | -2.44 | -9.76 | NA | Q4 2019 2/27/2020 | 52.01 | -3.25 | -13.00 | NA | Q3 2019 11/12/2019 | 141.55 | -3.48 | -13.92 | NA | Q2 2019 8/6/2019 | 162.34 | -3.28 | -13.12 | NA | Q1 2019 5/2/2019 | 165.52 | -3.37 | -13.48 | NA | Q4 2018 2/19/2019 | 152.95 | -3.38 | -13.52 | NA | Q3 2018 11/6/2018 | 128.26 | -2.63 | -10.52 | NA | Q2 2018 8/7/2018 | 151.20 | -0.36 | -1.44 | NA | Q1 2018 5/3/2018 | 148.13 | -1.68 | -6.72 | NA | Q4 2017 2/22/2018 | 155.40 | -1.75 | -7.00 | NA | Q3 2017 11/2/2017 | 62.56 | -1.97 | -7.88 | NA | Q2 2017 8/3/2017 | 78.40 | -1.88 | -7.52 | NA | Q1 2017 5/9/2017 | 66.03 | -1.52 | -6.08 | NA | Q4 2016 2/23/2017 | 62.33 | -1.50 | -6.00 | NA | Q3 2016 11/3/2016 | 38.71 | -1.15 | -4.60 | NA | Q2 2016 8/9/2016 | 36.86 | -1.08 | -4.32 | NA | Q1 2016 5/5/2016 | 34.79 | -0.97 | -3.88 | NA | Q4 2015 2/24/2016 | 30.75 | -0.99 | -3.96 | NA | Q3 2015 11/5/2015 | 53.03 | -0.84 | -3.36 | NA | Q2 2015 8/12/2015 | 62.47 | -0.90 | -3.60 | NA | Q1 2015 5/14/2015 | 58.29 | -0.66 | -2.64 | NA | Q4 2014 2/27/2015 | 43.45 | -0.57 | -2.28 | NA | Q3 2014 11/11/2014 | 33.98 | -0.50 | -2.00 | NA | Q2 2014 8/14/2014 | 28.81 | -4.57 | -18.28 | NA |
|
On this page we presented the SAGE PE Ratio History information for Sage Therapeutics' stock.
The average SAGE PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SAGE PE ratio history based on this TTM earnings result method is 5.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this SAGE PE ratio history result, against the recent PE: when this page was posted on 10/30/2024, the most recent closing price for SAGE had been 6.44, and the most recent quarterly earnings result, annualized, was 72.76. Meanwhile, the most recent TTM earnings summed to 12.51. From these numbers, we calculate the recent SAGE PE on 10/30/2024 based on annualized quarterly EPS was 0.1. Based on SAGE's history, that recent PE is low relative to the historical average, with the recent PE 91.7% lower than the historical average PE across our data set for Sage Therapeutics. Looking at the recent SAGE PE on 10/30/2024 based on TTM EPS, we calculate the ratio at 0.5. Based on SAGE's history, that recent PE is low relative to the historical average, with the recent PE 90.0% lower than the average PE across our Sage Therapeutics data set with TTM EPS used in the calculation at each period.
For self directed investors doing their due diligence on SAGE or any other given stock, valuation analysis for SAGE
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Sage Therapeutics PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for SAGE. Thanks for visiting, and the next
time you need to research SAGE PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.